Biodexa Pharmaceuticals Plc (BDRX) stock declined over -7.62%, trading at $5.55 on NASDAQ, down from the previous close of $6.01. The stock opened at $5.61, fluctuating between $5.06 and $6.30 in the recent session.
Biodexa Pharmaceuticals Plc, a drug delivery technology company, focuses on the bio-delivery and biodistribution of medicines in Belgium and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTX223, a long-acting injectable formulations of biologic products, such as mAbs or other high molecular weight proteins. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Employees | 21 |
Beta | 1.452 |
Sales or Revenue | N/A |
5Y Sales Change% | 0% |
Fiscal Year Ends | N/A |
Sector | Healthcare |
Industry | Biotechnology |
Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) stock price is $5.55 in the last trading session. During the trading session, BDRX stock reached the peak price of $6.30 while $5.06 was the lowest point it dropped to. The percentage change in BDRX stock occurred in the recent session was -7.62% while the dollar amount for the price change in BDRX stock was -$0.46.
The NASDAQ listed BDRX is part of Biotechnology industry that operates in the broader Healthcare sector. Biodexa Pharmaceuticals Plc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
No Data
BDRX's closing price is 9.64% higher than its 52-week low of $5.06 where as its distance from 52-week high of $220.25 is -97.48%.
Number of BDRX employees currently stands at 21.
Official Website of BDRX is: https://www.biodexapharma.com
BDRX could be contacted at phone 442 920 480180 and can also be accessed through its website. BDRX operates from 1 Caspian Point, Cardiff, CF10 4DQ, United Kingdom.
BDRX stock volume for the day was 85.79K shares. The average number of BDRX shares traded daily for last 3 months was 60.33K.
The market value of BDRX currently stands at $1.69M with its latest stock price at $5.55 and 304.44K of its shares outstanding.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com